KPTA vows to protect domestic pharmaceutical industry

Published: 2006-12-19 06:59:00

Updated: 2006-12-19 06:59:00

"We will have to resort to a lawsuit to fend off the government's new drug pricing policy that will shake up the domestic pharmaceutical industry, the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement.

The KPMA said the majority of domestic pharmaceutical firms cannot b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK